PME signs A$25M – 7 year contract with NYU Langone Health

Page 1 of 1
  1. 71.5k
    Posts

    11 September 2020
    HIGHLIGHTS
    • PME signs 7-year, A$25M deal with NYU Langone Health
    • NYU Langone ranked in the 10 best hospitals by U.S. News & World Report 2020-
    2021
    • Tier 1 academic institution which includes the renowned NYU Grossman School of
    Medicine
    • Visage technology to be deployed throughout NYU’s imaging departments replacing
    systems from legacy vendors
    • Extends PME’s footprint in the tier 1 U.S. academic hospital segment
    • Transaction-based model with potential upside
    Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its whollyowned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year contract with NYU Langone
    Health (NYU Langone), one of the largest health systems in the state of New York and one of the
    most respected and innovative healthcare institutions in North America.
    The contract, based on a transaction-based licensing model, will see the company’s Visage 7
    technology implemented across all of NYU Langone’s radiology and subspecialty imaging
    departments, including breast imaging, replacing all existing legacy PACS with a single centralized
    instance of the Visage 7 Enterprise Imaging Platform.
    The implementation will span 6 hospitals and numerous additional locations across the NYU
    Langone healthcare network. Planning for the rollout is to commence in Q2 FY21, with the first
    sites scheduled to go-live in Q3 FY21.
    Pro Medicus Limited
    450 Swan Street Richmond
    Victoria 3121 Australia
    T +61 3 9429 8800
    F +61 3 9429 9455
    www.promed.com.au
    Pro Medicus Limited
    ABN 25 006 194 752
    “NYU Langone completed a thorough selection process that required the final round of vendors to
    perform extensive on-site pilots. This enabled NYU to assess the differences between systems
    and, importantly, do so in their production environment, which is the ultimate test of how a product
    will perform,” said Dr Sam Hupert, Pro Medicus CEO. “Winning this deal further validates our belief
    that we have a unique and highly differentiated offering. We stream the pixel data, unlike others
    who still compress-and-send the images.”
    “We look forward to our new partnership with Visage as we implement their technology across our
    network,” said Dr Michael Recht, the Louis Marx Professor and Chair of the Department of
    Radiology at NYU Langone. “We are confident that this decision will lead to further expansion of
    our services and improved quality outcomes for those who turn to us for assistance.”
    NYU Langone is also home to the renowned NYU Grossman School of Medicine, ranked in the top
    5 medical schools in the U.S.
    Dr Hupert continued, “NYU Langone is a very significant addition to our rapidly growing North
    American footprint. More than any other PACS vendor, we now have 7 of the top 20 ranked U.S.
    hospitals standardising on our technology and are looking to grow that further across additional
    market segments. We believe the network effect of this and other recent wins positions us well to
    increase our lead in this highly competitive market.”
    Authorised by the Board of Pro Medicus Limited

    courtesy of Bell Direct
    ===============================================================================================================

    DYOR

    i hold PME ( 'free-carried' )

    this deal is more complex than it seems

    take care

  2. 71.5k
    Posts

    PME signs Research Collaboration agreement with NYU Langone Health
    11 September 2020
    HIGHLIGHTS
    • PME signs multi-year Research Collaboration agreement with NYU Langone Health
    • PME and NYU Langone to jointly develop next-generation enterprise imaging
    solutions
    • PME to establish Research/R&D Hub in New York City
    • New Hub to form the foundation for Visage research activities in the U.S.
    • Significant investment in future PME products
    Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its whollyowned U.S. subsidiary, Visage Imaging, Inc., has signed a multi-year Research Collaboration
    agreement with NYU Langone Health (NYU Langone), one of the most highly regarded health
    systems in North America.
    Under the terms of the agreement, the two parties will work together to design and develop nextgeneration products for enterprise imaging in areas such as workflow optimization, integration with
    multi-vendor reporting platforms, as well as integration of artificial intelligence (AI) technology. NYU
    Langone will also become a member of the Visage AI Accelerator program.
    “This is a major milestone for our company,” said Dr Sam Hupert, Pro Medicus CEO. “We changed
    the paradigm of what a diagnostic imaging (PACS) product should be by natively integrating 3D
    and advanced visualisation into a single platform. We believe this, combined with our proprietary
    streaming platform, has given us an 18 to 24 month technology lead. We are now looking at what
    is next, what a system would look like in say 3 to 5 years, and are starting to do the research and
    development to make that a reality and then be the first to commercialise it.”
    Pro Medicus Limited
    450 Swan Street Richmond
    Victoria 3121 Australia
    T +61 3 9429 8800
    F +61 3 9429 9455
    www.promed.com.au
    Pro Medicus Limited
    ABN 25 006 194 752
    In addition to working on-premise at NYU Langone, PME will establish its own R&D Hub in New York
    City to spearhead PME’s research and commercialization opportunities in the U.S.
    “Having our own R&D presence in North America will enable us to leverage the development and
    commercialisation potential of our Visage AI Accelerator and other programs across our rapidly
    increasing base of North America’s top academic, research-oriented clients. We see this as a
    significant investment in our future, one that will provide us with a strategic advantage in the rapidly
    evolving fields of enterprise imaging and AI.”
    “We are excited to collaborate with Visage in the areas of image viewing, workflow optimization
    and the incorporation of artificial intelligence into the daily workflow of radiologists,” said Dr Michael
    Recht, the Louis Marix Professor and Chair of Radiology at NYU Langone. “The integration of
    Visage’s development team, and NYU Langone radiologists and imaging scientists, will create a
    unique synergy and the potential for significant advances in these areas.”
    Authorised by the Board of Pro Medicus Limited.

    courtesy of Bell Direct
    ===================================================================================================

    DYOR

    some more info

Your browser is too old for TopStocks and not secure. Please update your browser